S-1: Healthcare Triangle Files for Resale of Up to 1.48 Billion Shares of Common Stock

Healthcare Triangle, Inc. has filed a registration statement for the potential resale of up to 1,483,809,885 shares of its common stock by selling stockholders.

Summary

• Healthcare Triangle, Inc. has filed a registration statement for the offer and sale of up to 1,483,809,885 shares of common stock by selling stockholders.
• The shares consist of (i) up to 7,017,429 shares purchased from the company, (ii) up to 29,173,056 shares issuable upon exercise of pre-funded warrants, (iii) 361,904,850 shares issuable upon exercise of Series A warrants at $0.084 per share, and (iv) 1,085,714,550 shares issuable upon exercise of Series B warrants using a cashless exercise and resetting the exercise price to $0.084 per share.
• The company will not receive any proceeds from the sale of these shares by the selling stockholders, except for proceeds from cash exercises of the Purchase Warrants.
• The selling stockholders may sell these shares through public or private transactions at prevailing market prices or negotiated prices.
• The company's common stock is listed on the Nasdaq Capital Market under the symbol HCTI, and the closing sale price on March 31, 2025, was $0.2996.
• The company is an emerging growth company and a smaller reporting company, which allows it to take advantage of certain reduced reporting requirements.
• The company's principal executive office is located in Pleasanton, CA.
• The company has agreed to file the Registration Statement for all of the Registrable Securities within five (5) calendar days of filing its Annual Report on Form 10-K for fiscal year 2024 and has agreed that the Registration Statement shall be effective no later than 45 days after the filing of such 10-K (if the Securities and Exchange Commission (the SEC) has no comments on the Registration statement and no later than 75 days after the filing of such 10-K if the SEC does have comments.

Sentiment

Score: 4

Explanation: The document is primarily a registration statement, which is a neutral event. However, the large number of shares being registered for resale could create downward pressure on the stock price, leading to a slightly negative sentiment.

Positives

• The registration statement allows selling stockholders to offer their shares for resale, potentially increasing liquidity.
• The company may receive proceeds from the cash exercise of warrants.
• The company's status as an emerging growth company and smaller reporting company allows for reduced reporting requirements, potentially saving costs.
• The company has established partnerships with Medical Information Technology, Inc. MEDITECH, Epic Systems, Splunk Inc., Snowflake Inc., Looker Inc. (acquired by Google), and other technology companies.

Negatives

• The company will not receive any proceeds from the sale of shares by the selling stockholders, except for proceeds from cash exercises of the Purchase Warrants.
• Future sales of substantial amounts of the company's common stock could adversely affect the market price of the common stock.
• The issuance of shares upon exercise of derivative securities may cause immediate and substantial dilution to the company's existing stockholders.
• The company has agreed to pay a daily penalty to the selling stockholders equal to 0.1% of the subscription amount of the Unit offering for each day it fails to meet the deadlines described above.

Risks

• An active trading market for the company's shares may not be sustained.
• Future sales of substantial amounts of the company's common stock could adversely affect the market price of the common stock.
• The issuance of shares upon exercise of derivative securities may cause immediate and substantial dilution to the company's existing stockholders.
• The company's ability to effectively operate its business segments is a risk factor.
• The company's ability to manage its research, development, expansion, growth, and operating expenses is a risk factor.
• Changes or delays in government regulation relating to the healthcare and Life Sciences industries are a risk factor.
• The company's ability to evaluate and measure its business, prospects, and performance metrics is a risk factor.
• The company's ability to compete, directly and indirectly, and succeed in the highly competitive and evolving ridesharing industry is a risk factor.
• The company's ability to respond and adapt to changes in technology and customer behavior is a risk factor.
• The company's ability to protect its intellectual property and to develop, maintain and enhance a strong brand is a risk factor.

Future Outlook

The company intends to retain future earnings, if any, to finance operations and expand its business and does not anticipate paying any cash dividends on its shares in the foreseeable future.

Industry Context

The company operates in the healthcare information technology sector, providing cloud services, data science, and professional and managed services for the Electronic Health Record (EHR), healthcare and life sciences industry.

Comparison to Industry Standards

• The Company, along with SecureKloud Technologies, Inc., a Nevada corporation (SKT) who, as of March 31, 2025, owns 28.3% of our common stock and all of our Series B Convertible Preferred Stock, is a born-on-the-cloud Premier Partner of AWS and an audited next generation MSP.
• The Company, along with SKT, is currently one of the top tier healthcare and life sciences competency partners of AWS among more than 100,000 partners in their global community of partners.
• The Company is also recognized as one of the top eight partners of Google Cloud Healthcare Interoperability Readiness Program.
• SKT was rated in 2021 by Solutions Review, an independent online magazine, as one of the 22 best AWS-managed services providers.

Stakeholder Impact

• Shareholders may experience dilution if warrants are exercised.
• The market price of the common stock could be affected by the sale of a large number of shares.
• The company's ability to raise capital in the future could be affected by the potential sale of shares by selling stockholders.

Next Steps

• The selling stockholders may sell their shares from time to time through various methods.
• The company will file post-effective amendments to the registration statement as required.
• The company has agreed to file the Registration Statement for all of the Registrable Securities within five (5) calendar days of filing its Annual Report on Form 10-K for fiscal year 2024 and has agreed that the Registration Statement shall be effective no later than 45 days after the filing of such 10-K (if the Securities and Exchange Commission (the SEC) has no comments on the Registration statement and no later than 75 days after the filing of such 10-K if the SEC does have comments.

Key Dates

Keywords

common stock, selling stockholders, warrants, registration statement, healthcare triangle, HCTI, resale, securities, offering, shares